China’s 240-Hour Transit Policy Explained

China’s 240-Hour Transit Without Visa Policy: A Comprehensive Guide (2026 Latest Edition)

China’s 240-hour transit without visa policy has been comprehensively optimized and implemented since December 17, 2024, extending the original 72-hour and 144-hour transit without visa policies to a unified 240 hours (10 days). The applicable ports have been expanded to 65 open ports in 24 provinces, and the stay area covers 24 provinces (regions, municipalities). This is a core convenience policy for foreign travelers transiting through China for short stays. This article, in conjunction with the latest regulations from the National Immigration Administration, provides a complete overview of the eligibility requirements, list of countries, prohibited situations, and visa-free stacking rules, ensuring authoritative and comprehensive information.

I. Core Eligibility Requirements (All Must Be Met)

  1. Nationality Requirement: Only citizens of 55 designated countries holding valid passports or other international travel documents with at least 3 months of validity remaining;
  2. Itinerary Requirement: Holding a connecting ticket with confirmed dates and seats within 240 hours, transiting through China to a third country/region; no round trips within China;
  3. Port Requirement: Entering and exiting through one of the 65 designated open ports, including airports, seaports, and land ports; non-designated ports are not applicable;
  4. Stay Requirement: The duration of stay is calculated from midnight of the day following entry, with a maximum of 10 days; overstaying is not permitted;
  5. Activity Requirement: Limited to tourism, business, visiting relatives, and general visits; activities requiring a visa, such as work, study, and news reporting, are prohibited;
  6. Procedure Requirement: Fill out the arrival card and undergo border inspection; no prior visa application is required.

II. Complete List of 55 Eligible Countries

  • 40 European Countries: Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, Monaco, Russia, United Kingdom, Ireland, Cyprus, Bulgaria, Romania, Ukraine, Serbia, Croatia, Bosnia and Herzegovina, Montenegro, North Macedonia, Albania, Belarus, Norway;
  • 6 American Countries: United States, Canada, Brazil, Mexico, Argentina, Chile;
  • 2 Oceania Countries: Australia, New Zealand;
  • 7 Asian Countries: South Korea, Japan, Singapore, Brunei, United Arab Emirates, Qatar, Indonesia.

III. Countries Not Eligible for 240-Hour Transit Without Visa

All countries/regions except the 55 countries listed above are not eligible for this policy, including:

  1. Asia: India, Thailand, Malaysia, Vietnam, Philippines, Pakistan, Bangladesh, etc.;
  2. Africa: All countries (South Africa, Egypt, Nigeria, etc.);
  3. Europe: European countries not listed among the 55;
  4. Americas: Countries not listed, such as Cuba and Venezuela;
  5. Oceania: Pacific island nations other than Australia and New Zealand.
    Travelers from the above countries need to obtain a transit visa in advance when transiting through China, or they can only enjoy the 24-hour port transit without visa (without leaving the designated port area).

IV. Stacking Visa-Free Policies: Direct Visa-Free Entry Without Transit

Most countries among the 55 also enjoy China’s unilateral visa-free/mutual visa-exemption policy, allowing visa-free entry for stays of up to 30 days without needing to rely on the 240-hour transit policy:

  1. 9 countries are only eligible for the 240-hour transit visa exemption.
    These 9 countries are: Czech Republic, Lithuania, Serbia, Bosnia and Herzegovina, Albania, Belarus, Ukraine, United States, and Indonesia.
    Citizens of the above countries must provide a confirmed connecting flight ticket to a third country or region within 10 days when entering China to qualify for the transit visa exemption.

V. Prohibited Situations (Will Be Denied Even If Nationality is Eligible)

  1. No confirmed connecting itinerary, entering for a domestic destination, or overstaying;
  2. Engaging in prohibited activities such as work, study, news reporting, or religious proselytizing;
  3. Expired or fraudulent documents, or a history of negative entry records;
  4. Other situations deemed by border inspection as not permitted for entry.

VI. Core Advantages and Precautions of the Policy

  1. Port Coverage: Includes major ports such as Beijing Capital/Daxing Airport, Shanghai Pudong/Hongqiao Airport, Guangzhou Baiyun Airport, Hong Kong-Zhuhai-Macao Bridge, and Guangzhou-Shenzhen-Hong Kong Express Rail West Kowloon Station, covering air, sea, and land transport;
  2. Convenient Stay: Free movement within 24 provinces, allowing for inter-city travel and business negotiations to meet short-term itinerary needs;
  3. No Additional Fees: Visa-free entry incurs no processing fees and the procedure is simple;
  4. Consequences of Overstaying: Overstaying will result in penalties and affect future entry into China.

In summary, the 240-hour transit without visa policy is an efficient option for travelers from 55 countries transiting through China, while countries that also enjoy direct visa-free policies can easily enter without transit. Check your nationality, itinerary, and port of entry before traveling to enjoy China’s most convenient entry policies.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International
Dr. Yu Zhenkun
 

Title

 

Dr. Yu Zhenkun, MD, PhD

 

Chief of Otolaryngology-Head and Neck Surgery, BenQ Hospital Affiliated with Nanjing Medical University

 
Education
 
  • Medical Doctor & PhD, Postdoctoral Fellowship (Beijing Tongren Hospital & Memorial Sloan Kettering Cancer Center, USA)
 
Professional Experience
 
  • Vice Dean, Fourth Clinical Medical College of Nanjing Medical University
  • Professor & PhD Supervisor, Nanjing Medical University
  • Professor, Southeast University School of Medicine
  • Former Chief, Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital
  • Former Deputy Director, Beijing Institute of Otolaryngology
  • Former Professor & PhD Supervisor, Capital Medical University
  • Former President & Chief Expert, Nanjing Tongren Hospital
 
Clinical Specialties
 
  • Complex Otolaryngology-Head and Neck Surgery
  • Obstructive Sleep Apnea (Pediatric & Adult)
  • Precision Laryngeal Surgery (Vocal Cord Paralysis, Cricoarytenoid Joint Reduction)
  • Targeted Treatment for Laryngeal Papilloma
  • CO₂ Laser Minimally Invasive Surgery for Laryngeal Cancer
  • Voice-Preserving Laryngeal Cancer Surgery
  • Precision Thyroid Cancer Surgery
  • Multimodal Therapy for Hypopharyngeal Cancer
  • Salvage Surgery & Reconstruction for Recurrent Head and Neck Cancers
 
Academic Achievements
 
  • Editorial Board Member of over 10 Chinese & international journals (including Chinese Journal of Otorhinolaryngology-Head and Neck Surgery)
  • Author of over 200 peer-reviewed publications
  • Editor/Translator/Contributor to 23 textbooks
 
Honors & Awards
 
  • Distinguished Young Expert of Jiangsu Province
  • Overseas High-Level Talent of Jiangsu Province
  • Jiangsu Provincial “Double Innovation” Talent & Team Leader
  • Distinguished Medical Expert of Jiangsu Province
  • Chief Expert in Head and Neck Oncology (Jiangsu Province)
  • Beijing “New Century Hundred-Thousand-Ten Thousand Talents” Program Recipient
  • Beijing Municipal Health System “Ten-Hundred-Thousand” Talent
  • Distinguished Physician Award, Chinese Medical Association of Otolaryngologists
  • Outstanding Young Investigator Award, Chinese Society of Otorhinolaryngology-Head and Neck Surgery
 
Professional Memberships
 
  • Executive Director (China), International Federation of Head and Neck Oncology Societies (IFHNOS)
  • Standing Committee Member, Asia Pacific Thyroid Surgery Association (APTS)
  • Committee Member, Laryngeal Cancer Quality Control Board, National Cancer Center
  • Standing Committee Member, Chinese Medical Association of Otolaryngologists
  • Standing Committee Member, Chinese Anti-Cancer Association Head and Neck Oncology Committee
  • Standing Committee Member, China International Exchange and Promotion Association for Medical and Healthcare (Otolaryngology Branch)
  • Chairman, Chinese Association of Non-Public Medical Institutions (Otolaryngology-Head and Neck Surgery Branch)
  • Standing Committee Member, Jiangsu Medical Association (Otolaryngology-Head and Neck Surgery Branch)
  • Vice President, Jiangsu Medical Association of Otolaryngologists

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International

请审查以下重要信息,包括护照、签证等信息

护照信息
您的护照必须在旅程结束后至少有效六(3)个月,并且入境和出境印章应至少有两(2)页空白签证页。

我们提供简便高效的美国护照和签证处理服务,会以枫林国际旅行社的身份给您发旅游邀请函,有需要可以联系我们,需支付服务费150美金

签证信息
作为游客,您需完全负责确保携带进入中国所需的旅行证件,非免签国家游客进入中国需持旅游签证,必须在出发前直接向中国领事馆申请或通过签证处理服务获得。持有有效10年期多次入境中国签证且持有过期护照且个人信息未变的旅客,出行时必须携带过期护照和新护照。如果被要求提供在中国接待您的旅行社,请注明枫林国际旅行社:代理机构#350484

注意:请勿表示计划前往西藏,否则申请将被拒。所有前往西藏的旅客都需要特别许可,枫林国旅将代为办理。请确保在出发前60天内提供高质量的护照信息页和有效的中国签证复印件以便我们办理入藏手续。

只有当您从南美或非洲黄热病流行区抵达或经过该地时,才需要在抵达前至少10天接种黄热病疫苗。CDC和WHO各自提供了所有受影响国家的最新名单。请务必携带医生提供的国际疫苗接种证明,否则可能会被拒绝入境。如果医生建议不要接种疫苗,他们可以提供必要的相关文件。

有任何不清楚的地方可以向我们咨询,我们乐意为您解答。

—–枫林国际旅行社

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Selected Value: 1
Selected Value: 0
Selected Value: 0